CIBA-GEIGY’s AREDIA (PAMIDRONATE) RECOMMENDED FOR APPROVAL IN TREATMENT OF HYPERCALCEMIA OF MALIGNANCY; LABELING SHOULD STRESS PATIENT MONITORING

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".